Protect AF evaluated the Watchman left atrial appendage (LAA) closure technology versus the current standard of care, warfarin, in patients with non-valvular atrial fibrillation at risk of stroke.
MASP-2, or mannan-binding lectin-associated serine protease-2, mediates activation of the complement system via the lectin pathway and is linked to multiple potential indications across a wide range of
Under the partnership, Medco and the FDA will jointly develop research projects, programs and strategies in the area of pharmacogenomics, collectively aimed at improving patient health and quality
Intended for use by donor centers, reference laboratories and hospitals for blood group serology testing, these traditional blood bank reagents complement Biotest’s existing portfolio of automated reagents that
The agreement is subject to the approval of the Oncologix shareholders and to the agreement of the University of Maryland to certain changes in the master license agreement
According to the company, the Epicor LP system has a lower profile as well as other features designed to facilitate easier device introduction and placement around and on
APP has nine products manufactured at its Puerto Rico facility, including doxycycline, azithromycin and diphenhydramine. The company anticipates manufacturing more than 19 million units in Puerto Rico during
The announcement follows the FDA’s peripheral and central nervous system drugs advisory committee’s unanimous decision in December 2007 to recommend Xenazine for approval. Cambridge owns the worldwide rights
The shares of common stock were issued in a private placement transaction under Regulation D of the Securities Act of 1933 and have not been registered under the
Under the terms of the 2006 agreement between Seikagaku (SKK) and Can-Fite, Can-Fite will receive a consideration of $1 million upon clinical trial initiation. Under the agreement, Can-Fite
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.